| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |